Mark H. Mirochnick, MD

Professor, Pediatrics

Biography

Mark Mirochnick, MD is Professor of Pediatrics and Chief of the Division of Neonatology at Boston University School of Medicine/Boston Medical Center. His main research involves investigating the effects of antiretrovirals in infants, children and pregnant women. He has served as protocol chair, investigator and/or protocol pharmacologist for HIV protocols on more than two continents. He currently serves as co-chair of the US Perinatal HIV Guidelines Committee and is a member of numerous Committees for HIV research including the WHO Pediatric Antiretroviral Working Group.

Other Positions

  • Section Director, Neonatology, Pediatrics, Boston University School of Medicine
  • Active Staff Privileges, Pediatrics, Boston Medical Center

Education

  • University of Vermont College of Medicine, MD
  • Dickinson College, BSc

Publications

  • Published on 7/1/2018

    Eke AC, Chakhtoura N, Kashuba A, Best BM, Sykes C, Wang J, Stek AM, Smith E, Calabrese S, Capparelli EV, Mirochnick M. Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum. J Acquir Immune Defic Syndr. 2018 Jul 01; 78(3):308-313. PMID: 29528944.

    Read at: PubMed
  • Published on 3/27/2018

    Mulligan N, Best BM, Wang J, Capparelli EV, Stek A, Barr E, Buschur SL, Acosta EP, Smith E, Chakhtoura N, Burchett S, Mirochnick M. Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV. AIDS. 2018 Mar 27; 32(6):729-737. PMID: 29369162.

    Read at: PubMed
  • Published on 3/15/2018

    Schreiner CN, Ahlfors CE, Wong RJ, Stevenson DK, Clarke DF, Mirochnick M. In Vitro Study on the Effect of Maraviroc or Dolutegravir on Bilirubin to Albumin Binding. Pediatr Infect Dis J. 2018 Mar 15. PMID: 29561509.

    Read at: PubMed
  • Published on 3/9/2018

    Adachi K, Xu J, Ank B, Watts DH, Camarca M, Mofenson LM, Pilotto JH, Joao E, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Machado DM, Ceriotto M, Morgado MG, Bryson YJ, Veloso VG, Grinsztejn B, Mirochnick M, Moye J, Nielsen-Saines K. Congenital CMV and HIV Perinatal Transmission. Pediatr Infect Dis J. 2018 Mar 09. PMID: 29528912.

    Read at: PubMed
  • Published on 3/8/2018

    Schalkwijk S, Ter Heine R, Colbers AC, Huitema ADR, Denti P, Dooley KE, Capparelli E, Best BM, Cressey TR, Greupink R, Russel FGM, Mirochnick M, Burger DM. A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women. Clin Pharmacokinet. 2018 Mar 08. PMID: 29520730.

    Read at: PubMed
  • Published on 2/1/2018

    Pinto JA, Capparelli EV, Warshaw M, Zimmer B, Cressey TR, Spector SA, Qin M, Smith B, Siberry GK, Mirochnick M. A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines. Pediatr Infect Dis J. 2018 Feb; 37(2):e29-e35. PMID: 29088027.

    Read at: PubMed
  • Published on 1/5/2018

    Adachi K, Xu J, Yeganeh N, Camarca M, Morgado MG, Watts DH, Mofenson LM, Veloso VG, Pilotto JH, Joao E, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado DM, Bryson YJ, Grinsztejn B, Moye J, Klausner JD, Bristow CC, Dickover R, Mirochnick M, Nielsen-Saines K. Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission. PLoS One. 2018; 13(1):e0189851. PMID: 29304083.

    Read at: PubMed
  • Published on 11/27/2017

    Friedman JF, Olveda RM, Mirochnick MH, Bustinduy AL, Elliott AM. Praziquantel for the treatment of schistosomiasis during human pregnancy. Bull World Health Organ. 2018 Jan 01; 96(1):59-65. PMID: 29403101.

    Read at: PubMed
  • Published on 11/8/2017

    Clarke DF, Penazzato M, Capparelli E, Cressey TR, Siberry G, Sugandhi N, Mirochnick M. Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations. Expert Rev Clin Pharmacol. 2018 Jan; 11(1):83-93. PMID: 29039686.

    Read at: PubMed
  • Published on 5/24/2017

    Rimawi BH, Johnson E, Rajakumar A, Tao S, Jiang Y, Gillespie S, Schinazi RF, Mirochnick M, Badell ML, Chakraborty R. Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy. Antimicrob Agents Chemother. 2017 Jun; 61(6). PMID: 28348149.

    Read at: PubMed

View 94 more publications: View full profile at BUMC

View all profiles